Human c-Myc isoforms differentially regulate cell growth and apoptosis in Drosophila melanogaster. by Benassayag, C et al.
University of Zurich
Zurich Open Repository and Archive
Winterthurerstr. 190
CH-8057 Zurich
http://www.zora.unizh.ch
Year: 2005
Human c-Myc isoforms differentially regulate cell growth and
apoptosis in Drosophila melanogaster
Benassayag, C; Montero, L; Colombié, N; Gallant, P; Cribbs, D; Morello, D
Benassayag, C; Montero, L; Colombié, N; Gallant, P; Cribbs, D; Morello, D. Human c-Myc isoforms differentially
regulate cell growth and apoptosis in Drosophila melanogaster. Mol. Cell. Biol. 2005, 25(22):9897-909.
Postprint available at:
http://www.zora.unizh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.unizh.ch
Originally published at:
Mol. Cell. Biol. 2005, 25(22):9897-909
Benassayag, C; Montero, L; Colombié, N; Gallant, P; Cribbs, D; Morello, D. Human c-Myc isoforms differentially
regulate cell growth and apoptosis in Drosophila melanogaster. Mol. Cell. Biol. 2005, 25(22):9897-909.
Postprint available at:
http://www.zora.unizh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.unizh.ch
Originally published at:
Mol. Cell. Biol. 2005, 25(22):9897-909
Human c-Myc isoforms differentially regulate cell growth and
apoptosis in Drosophila melanogaster
Abstract
The human c-myc proto-oncogene, implicated in the control of many cellular processes including cell
growth and apoptosis, encodes three isoforms which differ in their N-terminal region. The functions of
these isoforms have never been addressed in vivo. Here, we used Drosophila melanogaster to examine
their functions in a fully integrated system. First, we established that the human c-Myc protein can
rescue lethal mutations of the Drosophila myc ortholog, dmyc, demonstrating the biological relevance of
this model. Then, we characterized a new lethal dmyc insertion allele, which permits expression of
human c-Myc in place of dMyc and used it to compare physiological activities of these isoforms in
whole-organism rescue, transcription, cell growth, and apoptosis. These isoforms differ both
quantitatively and qualitatively. Most remarkably, while the small c-MycS form truncated for much of
its N-terminal trans-activation domain efficiently rescued viability and cell growth, it did not induce
detectable programmed cell death. Our data indicate that the main functional difference between c-Myc
isoforms resides in their apoptotic properties and that the N-terminal region, containing the conserved
MbI motif, is decisive in governing the choice between growth and death.
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The human c-myc proto-oncogene, implicated in the control of many cellular processes including cell growth
and apoptosis, encodes three isoforms which differ in their N-terminal region. The functions of these isoforms
have never been addressed in vivo. Here, we used Drosophila melanogaster to examine their functions in a fully
integrated system. First, we established that the human c-Myc protein can rescue lethal mutations of the
Drosophila myc ortholog, dmyc, demonstrating the biological relevance of this model. Then, we characterized a
new lethal dmyc insertion allele, which permits expression of human c-Myc in place of dMyc and used it to
compare physiological activities of these isoforms in whole-organism rescue, transcription, cell growth, and
apoptosis. These isoforms differ both quantitatively and qualitatively. Most remarkably, while the small
c-MycS form truncated for much of its N-terminal trans-activation domain efficiently rescued viability and cell
growth, it did not induce detectable programmed cell death. Our data indicate that the main functional
difference between c-Myc isoforms resides in their apoptotic properties and that the N-terminal region,
containing the conserved MbI motif, is decisive in governing the choice between growth and death.
The Myc family of proteins, originally identified because of
their cancer-inducing capacity in vertebrates, represents im-
portant and conserved regulators of cell processes including
growth, proliferation, and apoptosis (21). Myc proteins are
transcription factors possessing a basic helix-loop-helix leucine
zipper (bHLH-LZ) and act as heterodimers in either activating
or repressing transcription. Activation involves direct binding
of dimers formed between Myc and its bHLH-LZ partner Max
to target DNA sequences containing the E box CACGTG
motif (2, 5, 35, 50). Myc can repress transcription, acting
through association with Max or other protein partners such
as Miz-1 to prevent binding of the basal transcriptional ma-
chinery to Inr elements (36, 47, 52; for a review, see references
9 and 21). In mammals, three related Myc genes (c-myc, N-
myc, and L-myc) encode structurally related bHLH-LZ pro-
teins whose overexpression is associated with tumor induction
(20, 21, 30, 45). Moreover, in human, murine, and avian cells,
the c-myc gene encodes three distinct c-Myc protein isoforms:
Myc1, Myc2 (27), and a substantially shorter form called MycS
(25, 55). These three isoforms are translated from distinct
initiation sites, a noncanonical CUG codon for c-Myc1, an
AUG located 15 codons downstream for c-Myc2 (25, 27), and
an AUG 100 codons further downstream for c-MycS, respec-
tively (55). The resulting proteins contain the same carboxy-
terminal domain, including the bHLH-LZ motif, but differ in
their N-terminal regions. In particular, compared to c-Myc2,
c-Myc1 harbors a short N-terminal extension while the c-MycS
isoform lacks the first 100 amino acids (aa) of the transactivation
domain, including the well-conserved Myc box I (MbI) motif (55).
Several reports based on cell culture experiments suggest
that these alternative isoforms are functionally distinct. The
major variants c-Myc1 and c-Myc2 possess different trans-acti-
vation strengths and specificities towards the noncanonical
CCAAT/enhancer-binding protein binding site; moreover,
overexpression of c-Myc1, unlike that of c-Myc2, inhibits the
growth of COS cells (25, 26, 35). Furthermore, these isoforms
appear to be differentially regulated during cell growth, since
the c-Myc2 protein is predominant in growing cells while
c-Myc1 is preferred as cells approach high-density growth ar-
rest (28). By contrast, the accumulation of c-MycS in verte-
brate cells is transient during cell growth (55). Although this
truncated isoform has been suggested to act as a dominant-
negative inhibitor of trans activation by c-Myc1 and c-Myc2
proteins (55), it retains the ability to stimulate proliferation,
transform Rat1a fibroblasts, induce apoptosis under low-serum
conditions, and restore normal growth in Myc-null fibroblasts
(57). Finally, full-length c-Myc and c-MycS show differential
activities when assayed in primary versus immortalized cells,
pointing to the importance of cellular background (31). Taken
together, these observations show the complexity of Myc action
and underline the need to directly compare the respective
functions of the three isoforms in vivo. Such a study in the
mouse model is complicated both by the functional redun-
dancy of murine myc genes (38) and the complexity of their
transcriptional and posttranscriptional regulation (39).
Drosophila melanogaster represents a good model to analyze
the functions of the different human c-Myc isoforms in vivo for
several reasons. The Drosophila genome contains a single myc
gene, dmyc, which can be considered homologous to mamma-
lian c-myc, based on its sequence conservation (19, 53) and the
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ability of dMyc protein to restore proliferation to c-Myc-defi-
cient mouse embryonic fibroblasts (56). In addition, several
dmyc mutations have been described in Drosophila, and their
functional analyses reveal that dMyc protein regulates the
same cellular processes as c-Myc in mammals: cell growth,
proliferation and apoptosis (4, 13, 14, 34, 37, 42, 48, 51).
Finally, a recently isolated lethal P insertion mutation of dmyc
that expresses the yeast Gal4 transcriptional activator in the
place of dMyc (6) allowed us to express human c-Myc1,
c-Myc2, or c-MycS in place of the endogenous fly protein and
directly compare their respective functions.
Here we show that each human c-Myc isoform rescues lethal
dmyc mutations in Drosophila melanogaster, indicating that the
fruit fly is a relevant model for studying and comparing c-Myc
isoform functions in vivo. This comparison reveals markedly
different isoform activities both at the level of the whole or-
ganism for rescue and at the cellular level for induction of
proliferation and apoptosis. Strikingly, the transactivation do-
main-deleted c-MycS form rescues viability and normal prolif-
eration but is unable to induce apoptosis. The results of this
analysis, comparing the cellular activities of the three c-Myc
isoforms in a physiological context, indicate a crucial role of
the N-terminal region in modulating c-Myc activities in cell
growth and apoptosis.
MATERIALS AND METHODS
Drosophila stocks. Flies were maintained on standard corn meal-agar media at
22°C unless indicated. The y w line used as a control contains the isogenized X
chromosome used to generate the lethal P insertions (6). Other stocks are
described below.
Plasmid and transgene constructions. To construct the Myc1-encoding plas-
mid, RNA was extracted from the spleen of H-2/myc14 transgenic mice (49),
which express the human c-Myc1 protein but not c-Myc 2 (due to an ATG-
to-ATC mutation (see Fig. 2B). This RNA was reverse transcribed and amplified
with forward primer 5 GGAATTCCTTAGACGATGGATTTTTTTCGG
GTAG and reverse primer 5 GGGGTACCCCTTACGCACAAGAGTTCC
G 3 to generate the c-Myc1 PCR fragment. Subsequently, the noncanonical
CTG codon was mutated to ATG to ensure its efficient translation initiation (see
Fig. 2A and B). For Myc2- and MycS-encoding plasmids, total RNA was ex-
tracted from the human 293 cells, reverse transcribed, and amplified using either
5 GGAATTCCAGCCTCCCGCGACGATGCC 3 or 5 GGAATTCCACGG
CCGACCAGCTGGAG 3 as forward primers and 5 GGGGTACCCCTT
ACGCACAAGAGTTCCG 3 as the reverse primer. The 1,336-bp fragment
contains the coding sequences of human c-Myc2 protein, which is translated at
the canonical ATG initiation codon (see Fig. 2A). The 1,039-bp PCR fragment
harbors the coding sequence for c-MycS, translated from an ATG codon located
approximately 100 amino acids downstream from the ATG codon used to initiate
the translation of c-Myc2 protein (25, 49). These fragments were subcloned into
pGEMT Easy Vector (Promega) to generate pGEM c-Myc1, c-Myc2, and plas-
mids and sequenced. Their coding capacity was verified by subcloning each
cDNA into the pEGFP-N3 vector downstream of the cytomegalovirus promoter
(Clontech). 293 cells were transiently transfected using FuGENE 6 reagent
(Roche). Proteins extracted from transfected cells were visualized using the 9E10
anti-Myc monoclonal antibody in Western blot analysis. These cDNAs were then
placed under the control of upstream activation sequence (UAS) regulatory
elements by subcloning them into the pUAST vector (Invitrogen) or
pCaSpeR-hs (Flybase). Resulting UAS–c-Myc or heat shock protein 70 (hsp70)–
c-Myc plasmids were microinjected, and multiple independent transgenic flies
(4) were isolated for each. To obtain two copies of the c-MycS transgene, we
recombined two UAS–c-MycS transgenes on chromosome 2 or 3. To ensure that
these transgenic lines expressed the expected isoform, ubiquitous embryonic
expression of human c-Myc isoforms was induced by crossing two independent,
homozygous-viable UAS lines per isoform with a homozygous da-Gal4 driver
line ubiquitously expressing Gal4 under daughterless control. Proteins extracted
from 100 da-Gal4UAS–c-Myc embryos using Freon to remove yolk proteins
(16) were quantified using Bio-Rad DC (detergent-compatible) protein assay,
and 20 g of each extract was submitted to Western blot analysis. c-Myc isoforms
were detected using 9E10 anti-Myc monoclonal antibody. The membrane was
subsequently controlled for identical protein loading using an anti-actin mono-
clonal antibody (Chemicon).
Characterization of new dmyc alleles and genetic rescue. The dmycPL35 and
dmycPG45 insertions were maintained in heterogygous females, in combination
with a green fluorescent protein (GFP)-expressing “Green Balancer” chromo-
some: FM7, B Kr-Gal4 UAS–GFP (KrGFP) (7). Mutant male larvae could thus
be identified by the absence of fluorescence. To examine the effects of dmyc
mutants on growth, wing disks stained with a combination of phalloidin (cyto-
plasmic) and chromomycin (nuclear) markers were examined by confocal mi-
croscopy. The total surface of the disk was measured. In parallel, relative cell size
was estimated by counting the number of cells within two arbitrarily defined
areas, one in the presumptive wing pouch and one in the notum.
Rescue of dmycPL35 and dmycPG45 insertions was initially performed using
hsp70-dMyc or hsp70–c-Myc lines. Progeny were subjected to a 37°C heat shock
for 1 h each day until pupal formation. For rescue experiments based on Gal4
expression, heterozygous y w dmycPG45/FM7, B females were crossed with lines
homozygous for a UAS-dMyc or UAS–c-Myc transgene. At least two indepen-
dent UAS lines were tested for each isoform. Rescue was tabulated based on
eclosing B males, i.e., dmycPG45 males rescued by expression of transgenically
supplied Myc.
Rescued dmycPG45/Y; UAS–c-MycS/ males are viable and fertile. This al-
lowed us to test the nature of dmycPG45 and dmycPL35 by standard genetic
criteria, crossing rescued males with females heterozygous for dMycPL35 or
dMycPG45 or for a deficiency of the region [Df(1)75e19, 3C11;3E4;5E, and
Df(1)N8, 3C1;3D6]. Female B progeny obtained were of genotype dmycPG45/
dmycPL35; UAS–c-MycS/, dmycPG45/dmycPG45; UAS–c-MycS/, or dmycPG45/
Df; UAS–c-MycS/. Rescued adult females homozygous or hemizygous for
dmycPG45 showed a reproducible cleft between the two hemithoraces. Rescued
dmycPG45/dmycPL35 trans-heterozygotes showed an ameliorated phenotype com-
pared with rescued dmycPG45 homozygotes, confirming that dmycPL35 is hypo-
morphic. Thus, dmycPG45 is a strong loss-of-function allele by both formal ge-
netic and molecular criteria.
Mitotic recombination and clonal rescue. Mitotic clones were generated
by FLP/FRT-mediated site-specific recombination (58). The dmycPL35 and
dmycPG45 mutants isolated as lethal P insertions of the X chromosome (6) were
recombined with a Ub-GFP element on an X chromosome harboring a recom-
binase target site at cytological locus 18A (dmyc Ub-GFP FRT18A). The same
was also done with an arm-lacZ cytological marker (dmyc arm-lacZ FRT18A).
Clones of Ub-GFP-marked dmyc mutant cells were generated by crossing dMyc
Ub-GFP FRT18A/FM7, B females with arm-lacZ FRT18A; hsFlp MKRS/TM6B,
Tb males; conversely, for arm-lacZ-marked dmyc mutant clones, crosses em-
ployed dmyc arm-lacZ FRT18A/FM7, B females and Ub-GFP FRT18A; hsFlp
(86E) MKRS/TM6B, Tb males. Larvae of the progeny were heat shocked for 2 h
at 37.5°C at 48 and 72 h after egg deposition. Mutant clones and wild-type sister
clones were identified among the unrecombined sister cells by immunostaining
them with a polyclonal antibody against -galactosidase, which permits the dis-
tinction of one or two doses of arm-lacZ expression, and GFP fluorescence,
which likewise distinguishes one from two Ub-GFP copies. All viable cells in
resulting twin spot clones were thus positively marked.
To examine cell growth rescue in dmyc mutant cells by human c-Myc2 and
c-MycS isoforms, dmycPG45 arm-lacZ FRT18A/FM7; UAS–c-Myc/ females
were crossed with Ub-GFP FRT18A; C765hsFlp/TM6B Tb males. Two heat
shocks (2 h at 37.5°C) were performed at 48 and 72 h of development. At the end
of L3 (120 h), Tb female larvae harboring an hsFlp source were fixed, treated
with anti-lacZ antibody, and then dissected individually; their imaginal disks were
examined for the presence of mitotic clones. For genotyping, larvae were indi-
vidually dissected, and their imaginal disks were mounted. Four different classes
were found in the expected proportions corresponding to the following geno-
types: class 1, one-fourth are FM7, B/Ub-GFP FRT18A; class 2, one-fourth are
FM7, B/Ub–GFP FRT18A; UAS–c-Myc/; class 3, one-fourth are dmycPG45
arm-lacZ FRT18A/Ub-GFP FRT18A; and class 4, one-fourth are dmycPG45 arm-
lacZ FRT18A/Ub-GFP FRT18A; UAS–c-Myc/. Larvae of classes 1 and 2 do not
harbor mitotic clones. Class 3 larvae show a high frequency of twin spots, with the
mutant spot consistently much reduced as shown in Fig. 1E. Class 4 larvae are
distinguishable from class 3 larvae by the presence of twin spots with modified
relative sizes.
RNA extraction and reverse transcription-PCR (RT-PCR). Total RNAs were
extracted from 10 larvae or 100 embryos by the Trizol procedure following the
manufacturer’s instructions (Gibco BRL). One to 2 g of total RNA was reverse
transcribed using Superscript II RNase H reverse transcriptase (Gibco BRL)
and oligo(dT) primer in a final reaction volume of 20 l. Semiquantitative PCR
was performed using 0.5 l of reverse transcript sample per reaction mixture,
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FIG. 1. Characterization of lethal dmyc alleles dmycPG45 and dmycPL35. (A) Structure of dmyc, with three exons shown. The two lethal P
insertion mutations interrupt dmyc near the 5 extremity and in the second intron, respectively. Primer couples used for RT-PCR are indicated as
arrows above exons 2 and 3 and in the 3 untranslated region (3UTR). Riboprobes used for in situ hybridizations are indicated as lines under the
exons. (B) Freshly eclosed wild-type Oregon R adults (OreR) are compared with dead early pupae for dmycPG45 or dissected pharate adults for
dmycPL35. (C) Transcripts from wild-type and mutant dmyc. RNA from whole wild-type (Wt) or mutant larvae was subjected to RT-PCR, using
primer couples specific for exon 2 (red) or exon 2 and 3 (green), shown in panel A. crq mRNA served as an internal control. Shown are the results
corresponding to cycle 23. (D) dmyc mRNA was analyzed by in situ hybridization. Wing imaginal disks from normal (w) or mutant late L3 larvae
were examined using probes specific for exon 2 (D1, D2, and D3) or exon 3 (D4, D5, and D6). (E) Clonal twin-spot analysis shows the effect of
dmycPG45 and dmycPL35 on growth. Examples of typical clones are shown, with / cells seen in green and / cells in red. The histograms show
a representative spectrum of clones measuring growth of wild-type (/, green bars) and mutant (/, red bars) clones by their surface areas.
dmycPG45 mutant clones were about 10% the size of the wild type, while for dmycPL35, this value was 40%.
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200 nM each primer, and 2 U of Taq polymerase (Promega). The thermal cycling
conditions included an initial denaturation step (95°C for 5 min) and 20, 23, 26,
or 29 cycles (each cycle consisted of 94°C for 30 s, 58°C for 30 s, and 72° for 1
min). Experiments were performed in duplicate. The sequences of the different
primers used were as follows: crq (F), 5 GCTGGCTGGAGGCACCTATCC 3;
crq (R), 5 GCGGGAACATGTCGCCCGTGG 3; dmyc 275 (3/Ex2, F),
5 CCGACGACCGGCTCTGATAG 3; dmyc 276 (5/Ex3,R), 5 GGCACG
AGGGATTTGTGGGTA 3; or dmyc 277 (5/Ex2, F), 5 CGGCGATGTCCA
GCTGTTTG 3 and dmyc 278 (3/Ex2, R), 5 CGTCGGCGGAGAATCCAC
TG 3. For the autoregulation experiment, specific amplification of endogenous
dmyc mRNA was performed using NV3 (F) (5 GTTGGACGACGCGAAGAT
GAAAGAG 3) and NV7 (R) (5 GGCGGCGTACTTAAAGAAATGTAT
AAGG 3) specific to sequences which are absent from the 3 untranslated region
of the transgene. The control used corresponds to RP49 mRNA amplification
using NV1 (F) and NV2 (R) primers (5 AGATCGTGAAGAAGCGCA
CCAAGC 3 and 5 GCACCAGGAACTTCTTGAATCCGG 3, respectively).
In situ hybridization and immunocytology. Third-instar mutant larvae were
sorted by the absence of GFP fluorescence (FM7 “Green Balancer”) and then
carefully staged. RNA in situ hybridizations were carried out using digoxigenin-
labeled RNA probes. Immunostainings were carried out by standard procedures.
The antibodies and dilutions used were as follows: rabbit anti -
galactosidase (1/5,000; Cappel), mouse anti-digoxigenin (1/2,000), rabbit anti-
caspase 3, cleaved form (1/300; Cell Signaling Technology).
Flip-out clones. Females of genotype y w hsFlp; actCD2Gal4 UAS-GFP/
TM6B, Tb were crossed with males homozygous for a UAS-Myc transgene and
the offspring were raised at 25°C. At 48 h after egg deposition, the offspring were
subjected to a 3-h heat shock in an air incubator at 37°C.
Flow cytometry. Fluorescence-activated cell sorting (FACS) analysis of wing
imaginal disks harboring flip-out clones was performed as previously described
(43). Wing imaginal disks were isolated from up to 25 wandering larvae and
incubated for 4 to 5 h at 25° in 250 l of phosphate-buffered saline containing
4.5-g/l porcine trypsin–0.18-g/l EDTA–0.81% NaCl (Intergen) and 0.5-ng/
l Hoechst 33342. Analysis was carried out with a FACStar PLUS (Becton Dick-
inson), and the data were analyzed with WinMDI, version 2.8. Each genotype was
analyzed in at least two biologically independent experiments with qualitatively
identical results.
FIG. 2. Structure and expression of c-Myc proteins. (A) Block diagrams compare Drosophila Myc protein (d-Myc) with human c-Myc,
highlighting the bHLH-LZ domain of each protein, the c-Myc trans-activation domain (TAD) with its MbI and MbII motifs, and the related dMyc
sequences. Numbering of amino acid residues is indicated. For c-Myc, this is based on the c-Myc2 isoform (initiated at 1). Overall, the dMyc and
c-Myc sequences show 26% identity (19). The bHLH-LZ region involved in DNA binding and dimerization shows extensive identity (67%; 53 of
80 residues). Three different c-Myc translation initiation codons (CTG at 15, ATG at 1, and ATG at 100) give rise to c-Myc1, c-Myc2, and
c-MycS isoforms. (B) c-Myc transgenic constructs. For the c-Myc1 construction, the noncanonical CTG codon was modified to ATG, while the
alternate downstream ATG site was changed to ATC to limit initiation site choice. c-Myc2 and c-MycS constructs employed the usual ATG codons.
(C) Proteins extracted from transiently transfected culture cells were subjected to Western blot analysis and detected with anti-Myc monoclonal
antibody. A single band of the expected size was detected for each construct. (D) Proteins extracted from da-Gal4UAS–c-Myc embryos were
analyzed as described for panel C. Two independent transgenic lines were tested for c-Myc1, c-Myc2, and c-MycS. As for transfected cells, a single
protein band of the predicted size was seen for each construct.
TABLE 1. Developmental and cellular analysis of dmyc insertions
Genotype % Unhatchedembryosa
Days of pupal
formation at 25°C Lethal phase
Cell size in wing
disk (pixels/cell)
Rescue of dmyc males
by hsp70:dMyc
Control y w 11 6 Old age 625
PL35 11 8 Pharate adults 440 Viable adults
PG45 23 10 Prepharate pupae 411 Pharate adults
a The value for embryos reflects the sum of all genotypes; at later developmental phases, only mutants (GFP) were considered.
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RESULTS
Characterization of lethal dmyc insertions. In a recent sys-
tematic genetic screen for P element insertions that interrupt
essential genes on the Drosophila X chromosome, we isolated
two new dmyc insertions (PG45 and PL35), both associated
with recessive lethality (6). The PG45 (an enhancer trap ex-
pressing the Gal4 reporter gene) and PL35 (expressing lacZ)
lines are integrated adjacent to the putative dmyc transcription
start site and in the second intron, respectively (Fig. 1A).
Mutant males harboring either allele die throughout larval-
pupal development, with a delayed development compared to
that of wild-type controls (Table 1).
While a majority of PG45 male larvae die early in the pupal
stage, PL35 males die later, as pharate pupae of reduced size with
FIG. 3. Rescue of growth by c-Myc proteins in dmyc mutant cells. Representative clones were examined for/ (green) or dmycPG45/dmycPG45
(red) cells without c-Myc (A), expressing c-MycS (B), or c-Myc2 (C) from UAS constructs under dmycPG45 control as described in the text. At
bottom, a histogram summarizing the results from representative clones (n  number of clones analyzed) shows that human c-Myc restored cell
growth to about 70% and 100% of wild-type levels for cells expressing c-MycS and c-Myc2, respectively. Note that for mutant cells expressing
c-Myc2, the frequency of clones observed per disk was markedly reduced compared with clones of cells expressing c-MycS or for mutant cells alone.
TABLE 2. Transgenic rescue of the dmycPG45 mutant
dmycPG-45/FM7 	 UAS-
transgenic lines
(n)
Rescued males dmycPG45/Y; UAS-Myc Myc-overexpressing femalesdmycPG45/; UAS-Myc
% Viabilitya
Phenotype % Wing size
b
(n  40)
% Cell
sizec
% Viabilityd
18°C
(n  30)
22°C
(n  70)
26°C
(n  70)
18°C
(n  80)
22°C
(n  150)
26°C
(n  120)
UAS-dMyc (3) 0 0 0 30 (
5) 3 (
2) 0
UAS–c-Myc1 (6) 0 0 0 52 (
6) 41 (
1) 3 (
3)
UAS–c-Myc2 (4) 66 (
25) 30 (
15) 0 Normal bristles; sterile 90 93 100 66 (
3) 38 (
3)
UAS–c-MycS (6) 28 (
3) 40 (
2) 20 (
2) Thin bristles; fertile 85 83 100 100 78 (
3)
2 copies UAS–c-MycS
(2)
100 85 (
5) 55 (
5) Thin bristles; fertile ND ND 100 100 100
a Relative to FM7/Y males; n, number of males counted.
b Relative to wings of y w/Y males; n, number of wings counted.
c Relative to cell size of y w/Y male wings (see Materials and Methods).
d Relative to FM7/; UAS-Myc females; n, number of females counted. ND, not determined.
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FIG. 4. Human c-Myc isoforms regulate dMyc target genes. (A) Negative autoregulation of dmyc. RT-PCR was carried out with RNAs
extracted from embryos carrying da-Gal4 and a UAS transgene directing the expression of LacZ or dMyc (lines 3 and 132), or from wild type (w)
or selected dmycPG45; UAS-dMyc (line 3) larvae. Primer pairs (Fig. 1A and Materials and Methods) specifically amplified mRNAs from
endogenous dmyc (endo), both endogenous and transgenic dmyc (endo dmyc plus transgene) or RP49 (control). Shown are the results corre-
sponding to cycle 26 (endo), 23 (endo plus transgene) and 20 (RP49). (B) The imaginal disk-specific dpp-Gal4 driver was used to direct localized
overexpression of Myc forms from UAS constructs, in a central band of cells in otherwise wild-type wing imaginal disks (as seen for dmyc in B2).
The effect on transcription from dmyc (panels 1 to 5) or mod (panels 6 to 10) was detected by in situ hybridization to wing imaginal disks, using
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a thin bristle phenotype similar to that of previously described
dmyc alleles (Fig. 1B) (34). Heterozygous females are viable,
fertile, develop at a normal rate, and appear morphologically
normal as adults, showing that both insertions are recessive.
The lethality of PL35 and PG45 males can be attributed to
the P element insertions in dmyc for three reasons. First, le-
thality can be fully reverted by transposase-induced precise
excision (6; data not shown). Second, both insertions are as-
sociated with strongly reduced levels of dmyc mRNA in third-
instar male larvae, as assessed by semiquantitative RT-PCR
using different combinations of primers (Fig. 1C) and by in situ
hybridization to wing imaginal disks with exon-specific probes
(Fig. 1D). Whereas dmyc mRNA is normally expressed at high
levels in the wing pouch but is excluded from cells flanking the
dorsoventral boundary (Fig. 1D1 and 4) (19), only background
levels of dmyc mRNA were detected throughout the PG45
mutant disks for all probes tested (Fig. 1D2 and 5). In PL35
larvae, hybridization revealed accumulation of a truncated
mRNA containing exon 2 but not exon 3 (Fig. 1D3 and 6),
which was confirmed by RT-PCR with appropriate primers
(Fig. 1C). Third, the lethality of PL35 and PG45 mutants can
be rescued by expression of a dMyc transgene (Table 1) (32).
Taken together, the mutant phenotype, dmyc mRNA expres-
sion and transgenic rescue confirm that these insertions are
indeed dmyc loss-of-function mutations (that we refer to as
dmycPL35 and dmycPG45) with dmycPG45 being the stronger of
the two.
dmycPL35 and dmycPG45 insertions affect cell growth. It has
previously been shown that dmyc mutant cells grow poorly
compared to the wild type, as measured in vivo in a mitotic
recombination-cell competition assay (34). To estimate the
strength of the new, lethal dmyc alleles, we first compared relative
numbers and sizes of cells in wing imaginal disks of staged dmyc
mutant late third-instar larvae compared to the wild type (see
Materials and Methods). Total wing disk size was reduced by
30% for both mutants (Fig. 1D), and the mutant cell area was
also one-third smaller than that of the wild type (Table 1). The
similar reductions in the sizes of cells, imaginal disks (Fig. 1D),
and pupae (23 to 30% smaller in mutants) (Fig. 1B) indicate
that cell size is the primary determinant of organ size. Next, we
used the FLP/FRT system to induce site-specific mitotic re-
combination in female larvae heterozygous for dmycPG45 or
dmycPL35, and quantitated the relative growth of normal and
mutant cells by measuring the area of/ (green) and dmyc/
dmyc (red) cell clones. Both dmycPG45 and dmycPL35 mutant
clones grew poorly compared to their sister clones (Fig. 1E).
While the relative size of dmycPL35 mutant clones varied con-
siderably, from 0% to 100% of the wild-type twin (average
relative size, 40%) (Fig. 1E), the effect on cell growth was
invariably strong for dmycPG45, with an average mutant clone
size of about 10% of the wild-type twin (Fig. 1E). These data
show that dmycPG45 strongly affects cell growth and, taken
together with the above molecular characterization and formal
genetic analysis (see Materials and Methods), confirm that
dmycPG45 is a strong hypomorphic allele (37).
Human c-Myc isoforms differentially rescue lethal dmycmu-
tations. To test whether human c-Myc can replace dMyc func-
tion in vivo, we examined dmycPG45 and dmycPL35 mutant
males harboring hsp70–c-Myc transgenes (see Materials and
Methods and below). The lethal phase for dmycPG45 males was
retarded on inducing c-Myc1 or c-Myc2 expression (or for
dMyc [Table 1]), while a few mutant dmycPL35 adult males
survived. This result demonstrated a rescue capacity, but the
multiple heat shocks required were associated with widely vari-
able viability and limited rescue. We therefore focused on the
dmycPG45 insertion, which not only removes normal gene func-
tion but also expresses the Gal4 activator protein in a pattern
very similar to normal dmyc expression (data not shown). The
Gal4 activator protein was used to activate transcription of the
various UAS–c-Myc constructs through their UAS sequences.
The human c-Myc coding sequences were modified such that
the noncanonical CUG codon in c-Myc1 was replaced by an
AUG and the downstream AUG from which c-Myc2 transla-
tion is normally initiated was replaced by AUC (Fig. 2B and
Materials and Methods). Each cDNA directed the accumula-
tion of a single protein when transiently transfected in 293
cultured cells (Fig. 2C). We established at least four indepen-
dent UAS–c-Myc transgenic fly lines for each cDNA. To verify
expression of the appropriate c-Myc isoform in vivo, two inde-
pendent UAS lines for each isoform were crossed with a driver
line ubiquitously expressing Gal4 under daughterless control
(da–Gal4) and proteins extracted from the resulting embryos.
In each case, Western blot analysis showed the predicted
c-Myc isoform (Fig. 2D).
We next coupled UAS–Myc transgenes with the dmycPG45
mutation to test the ability of the three c-Myc isoforms to
rescue dmycPG45 mutant males. Such males were obtained by
crossing females heterozygous for dmycPG45 with males ho-
mozygous for each UAS–c-Myc insertion (at least four inde-
pendent lines). Since Gal4 activity is enhanced by increasing
temperature, expression levels for Myc proteins were modu-
lated by raising cultures in parallel at 18°C, 22°C, or 26°C. The
dmycPG45 insertion is fully lethal in hemizygous males, and thus
recovery of adult dmycPG45 males will demonstrate that the
transgenic Myc protein has compensated the loss of normal
dmyc function. Such males were observed on expressing either
c-MycS or c-Myc2 (Table 2), showing that despite poor overall
conservation, human c-Myc can rescue the loss of dMyc func-
tion in vivo.
However, the three c-Myc proteins tested were not equiva-
lent in this rescue assay. Indeed, rescued mutant males ex-
pressing c-MycS were viable and fertile for the six single-inser-
tion lines tested and for two recombinant lines carrying two
insertion copies, whereas surviving c-Myc2 expressing males
were sterile (four lines tested) (Table 2). In stark contrast, no
c-Myc1-expressing males were obtained for any line or growth
specific riboprobes (exon 2 for dmyc and full-length cDNA for mod). Endogenous dmyc and mod expression is shown in panels 1 and 6, respectively,
while patterns resulting from overexpressed Myc forms are shown for dMyc line 3 (panels 2 and 7), c-Myc1 line 18 (panels 3 and 8), c-Myc2 line
16 (panels 4 and 9) or c-MycS line 15 (panels 5 and 10). All c-Myc forms detectably repressed dmyc (left, arrows) and enhanced expression of mod
(right, arrows) in a central band of cells.
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condition tested (Table 2). This discrepancy is not due to
differences in expression level, since protein isoform accumu-
lation was similar for independent transgenic lines expressing
c-Myc1, c-Myc2, and c-MycS (Fig. 2D, compare Myc1-11
and -18 and Myc2-16 and MycS-15). The absence of rescue for
c-Myc1 (comparable to the dMyc control) (Table 2) may thus
reflect a dominant toxicity of this isoform under these expres-
sion conditions. This hypothesis is supported by the marked
effect of increasing culture temperature on survival of c-Myc1-
expressing dmycPG45/ female progeny (52% survival at 18°C
versus 3% at 26°C) (Table 2) or to a lesser extent for c-Myc2
(100% at 18°C versus 38% at 26°C) (Table 2). By contrast,
c-MycS-expressing females were fully represented at any tem-
perature, and addition of a second transgenic copy in mutant
males improved rescue efficiency (Table 2). Taken together,
these data suggest that human c-Myc isoforms differ qualitatively
in their action and notably that c-MycS—described as a transac-
tivation-deficient, dominant negative c-Myc form (57)—can effi-
ciently replace dMyc in vivo.
Human c-Myc isoforms restore Drosophila cell growth.
These rescue data strongly suggest that the various c-Myc pro-
teins are not functionally equivalent in the whole organism. To
better understand these differences, we examined the capaci-
ties of c-Myc2 and c-MycS to restore cellular growth in vivo.
Due to the dominant lethality associated with expression from
UAS-dMyc or UAS–c-Myc1, these forms could not be tested.
We made use of the FLP/FRT site-specific recombination sys-
tem to induce mitotic recombination in females heterozygous
for dmycPG45 and harboring a UAS–c-Myc transgene. Mitotic
recombination yielded twin recombinant clones of /; UAS–
c-Myc and mutant dmycPG45/dmycPG45; UAS–c-Myc cells, with
the former cells expressing only endogenous dmyc and the
mutant cells expressing transgenic c-Myc. In the absence of
c-Myc protein, the size of the mutant clone (red) was strongly
reduced compared to the (green) wild-type twin spot (10%)
(Fig. 1E and 3A). By contrast, growth rescue was observed in
clones of cells expressing either c-MycS or 2. This cellular
rescue appeared nearly complete for the c-Myc2-expressing
clones (Fig. 3C), while c-MycS-expressing clones were about
70% the size of the / twin (Fig. 3B). Similarly, c-Myc2-
rescued adults attained nearly normal size, while c-MycS-ex-
pressing adults were smaller by about 15%, as seen by wing size
(Table 2). We conclude that human c-Myc2 and c-MycS dif-
ferentially substitute for endogenous dmyc in promoting cell
growth and that the sizes of the resulting adults reflect different
cellular growth properties of these c-Myc isoforms.
Human c-Myc isoforms regulate dMyc target genes. The
functional rescue of dmyc mutations by c-Myc suggests that
human and Drosophila Myc proteins control common target
genes in vivo. To address this question, we examined the ca-
pacity of c-Myc isoforms to regulate known or potential dmyc
targets in flies. c-myc expression in mammals is subject to a
negative autoregulatory loop (17). To test whether a similar
regulatory mechanism exists in Drosophila, we overexpressed
transgenic dMyc and measured its effect on accumulation of
endogenous dmyc mRNA. The endogenous and transgenic
dmyc mRNAs differ in their 3 untranslated regions, making it
possible to specifically detect the endogenous mRNA by RT-
PCR (Materials and Methods). As shown in Fig. 4A, endoge-
nous dmyc expression was strongly reduced upon UAS-dMyc
expression directed either by da-Gal4 or by dmycPG45 drivers
(endo dmyc). This repression was inversely related to the level
of transgene expression (Fig. 4A, compare transgenic lines 3
versus 132). These data indicate the existence of a negative
autoregulatory mechanism conserved between mammals and
flies.
We next asked whether the different human c-Myc isoforms
can trans repress dmyc transcription, using the dpp-Gal4 driver
to direct their localized expression in a central band of cells at
the anteroposterior compartment boundary of wing imaginal
disks. We then examined dmyc mRNA accumulation by in situ
hybridization with a dmyc-specific exon 2 riboprobe (Fig. 1A).
The control experiment with UAS-dMyc showed a strong lo-
calized accumulation of dmyc mRNA, as expected for the dpp
promoter used (Fig. 4B2). In contrast, when human c-Myc
forms were expressed in the same manner, endogenous dmyc
mRNA was locally diminished (compare Fig. 4B1 to 4B3 to 5,
arrows). These observations indicate that all three human
c-Myc proteins can negatively regulate dmyc.
We next examined their capacity to trans activate the expres-
sion of two known dmyc target genes, pitchoune (pit) and mod-
ulo (mod). pit encodes an RNA helicase required for cell
growth (60), while the Modulo protein shows structural simi-
larity to nucleolin, which has a putative role in ribosome bio-
genesis (46). Expression of either pit or mod is strongly re-
duced in dmycPG45 or dmycPL35 mutants (46; data not shown).
To ask whether human Myc proteins can activate transcription
of these genes, we induced dMyc or isoform specific c-Myc
expression in the wing imaginal disk and then analyzed pit and
mod expression by in situ hybridization. Locally enhanced ex-
pression for mod (Fig. 4B7, arrow) or pit (not shown) was
induced by dMyc, compared with endogenous expression
(Fig. 4B6 and data not shown); similar, albeit weaker, enhance-
ment was observed with all three human c-Myc variants
(Fig. 4B8 to 10). Taken together, we conclude that fly and
human Myc proteins are able to regulate the same target
genes, whether negatively (dmyc) or positively (pit and mod).
Human c-Myc isoforms differentially modulate cell growth
and cell cycle progression. We next sought to compare the
activities of the three c-Myc isoforms for cellular functions in
vivo, i.e., cell growth, cell cycle progression, and apoptosis, by
examining the effects of their overexpression in a wild type
context. We therefore generated random clones of cells over-
expressing c-Myc1, c-Myc2, or c-MycS in imaginal wing disks
under the control of Gal4 by the flip-out technique
(actCD2Gal4; Materials and Methods) (43). Clones of
Gal4-expressing cells induced during larval development were
identified by cytoplasmic GFP expression from a UAS:GFP
reporter. Such GFP cells were then separated from nonex-
pressing cells by FACS, and both populations were examined
for cell size and DNA content. Expression of dMyc, used in a
control experiment, led to an increase in cell size (Fig. 5, left)
and a strong reduction in the fraction of cells in G1 with a
concomitant increase in cells in S or G2 phase (Fig. 5, right), as
previously described (34). Human isoforms c-Myc1 and 2 pro-
duced similar effects, albeit weaker than for dMyc (Fig. 5).
However, c-MycS, while promoting G1/S cell cycle progression,
had little effect on cell size (Fig. 5). To test whether this
difference might reflect limiting amounts of c-MycS activity, we
induced flip-out clones expressing two UAS–c-MycS copies
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FIG. 5. Effects of Myc overexpression on cell size and cell cycle distribution. Flip-out clones of cells expressing Gal4 were generated by FLP
recombinase derived from an hsFlp construct by heat induction 2 days after egg laying. Corresponding wing disks in third-instar larvae were
dissected 3 days later. Clonally derived cells expressing Myc proteins (UAS-Myc transgene) were identified by coexpression of the GFP marker
from a UAS-GFP transgene. Shown are representative FACS analyses of dissociated wing disk cells. (Left) Cellular size was assayed by forward
scatter (FSC). (Right) Cell cycle distribution was assessed by measuring accumulation of the DNA-intercalating dye Hoechst 33342. The vertical
axis indicates cell number; red traces correspond to control cells expressing neither GFP nor the Myc transgene; green traces correspond to cells
from the same wing disks but expressing the indicated Myc transgene together with GFP. To standardize the presentations, we set the 4C peak
of each green trace to the same level as the 4C peak of the corresponding red trace. The apparent overrepresentation of the 2C peak for the red
control curve observed in the right bottom panel reflects variation among experiments but is not isoform specific. To ensure the reliability of results
obtained from small cell numbers, the experiments were repeated several times (n).
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FIG. 6. Effects of overexpressing Myc forms on apoptosis and reaper gene expression. (Left) Immunofluorescence micrographs of intact wing
disks harboring flip-out clones of cells expressing the indicated transgenes in clones. The clones are recognized by their diffuse, evenly distributed
green staining (corresponding to UAS-GFP expression; examples are indicated by dotted lines). Bright green dots correspond to AO staining
typical of apoptotic cells. Intense AO staining was observed in clones of cells expressing dMyc (B) and c-Myc1 (C); lesser AO staining was seen
for c-Myc2-expressing cells (D), while apoptotic cells accumulating AO were not observed in control clones (A) or in clones expressing c-MycS
(E). (Middle) UAS-Myc transgenes were expressed in the dorsal compartment of wing imaginal disks under the control of ap-Gal4, and apoptosis
was detected by an antibody directed against activated caspase 3 (G to J). The approximate dorsoventral compartment boundary is indicated in
each image by a broken line, while the wing pouch is roughly delimited by an oval. The consequences of Myc expression are seen in the dorsal half
of the wing pouch (roughly corresponding to the upper half of the area marked by the oval). Whereas dMyc and c-Myc1 provoked strong apoptosis
(G and H), c-Myc2 and c-MycS samples (I and J) were similar to the lacZ control (F). Consistently high background levels of apoptosis independent
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rather than one. Under these conditions, the effect of c-MycS
on cell size-cell cycle progression resembled that of c-Myc1 and
c-Myc2 (Fig. 5).
Human c-Myc isoforms have different effects on apoptosis.
To ask whether Myc overexpression induces apoptosis, we
examined the uptake of the vital stain acridine orange (AO)
(1) in imaginal disks harboring Myc-expressing flip-out clones
(GFP). Apoptotic cells show intense nuclear staining with
this dye. High levels of apoptosis were observed within clones
of cells expressing dMyc, c-Myc1, or c-Myc2 (compare Fig. 6B
to D to Fig. 6A). In striking contrast, c-MycS did not induce
detectable apoptosis with one or two transgenic UAS–c-MycS
copies (Fig. 6E and data not shown). Similar results were
obtained with another experimental condition, where an ap-
Gal4 driver was used to express c-Myc isoforms in dorsal wing
disk cells (wing pouch and notum), and apoptosis was visual-
ized with an antibody directed against activated caspase 3, a
marker for apoptotic cells (40). Significant background levels
of localized apoptosis, presumably due to the ap-Gal4 inser-
tion, were observed outside the wing pouch for all samples
(Fig. 6F to J, arrows). However, strong additional apoptosis in
dorsal cells of the wing pouch was specifically observed on
overexpressing dMyc and c-Myc1 (compare Fig. 6G and H to
the control, shown in Fig. 6F). In contrast, c-Myc2 showed (at
most) modest induction (Fig. 6I), while none was noted for
c-MycS (Fig. 6J). This result confirms that c-Myc isoforms can
differentially induce apoptosis: strongly for c-Myc1, weakly for
c-Myc2, and none for c-MycS. We therefore next asked
whether the differential induction of apoptosis could reflect
different abilities of the human isoforms to activate the pro-
apoptotic reaper (rpr) gene, recently identified as a dMyc target
by a genome-wide search and shown to be up-regulated by
dMyc in vivo (14, 44). To this end, an independent driver line,
engrailed-Gal4, was used to direct Myc expression in posterior
cells of wing imaginal disks during larval development, and rpr
mRNA expression was examined by in situ hybridization. As
seen in Fig. 6L and M, posterior rpr mRNA expression was
markedly induced by dMyc and c-Myc1, and to a lesser extent
by c-Myc2 (Fig. 6N). However, only background levels of rpr
mRNA were observed upon c-MycS expression using one or
two copies of the transgene (Fig. 6O and not shown). Together,
these data indicate that the inability of the c-MycS isoform to
induce apoptosis in vivo is at least in part due to its inability to
activate rpr transcription.
DISCUSSION
In the present work, we have compared the capacity of the
three human c-Myc isoforms to rescue lethal dmyc mutations,
modulate cell growth, and induce apoptosis in Drosophila. All
three isoforms, but especially c-Myc2 and c-MycS, are capable
of restoring viability in dmyc mutants and of regulating dMyc
target genes in vivo. Thus, despite limited sequence identity, fly
and human Myc proteins are functionally conserved and de-
ploy a common network during Drosophila development. How-
ever, the rescue experiments and clonal analysis also revealed
marked functional distinctions among human c-Myc forms in
their ability to induce cell growth or programmed cell death.
Strikingly, the transactivation domain-truncated c-MycS iso-
form efficiently rescues fly viability and fertility when expressed
in place of dMyc but induces no detectable apoptosis in over-
expression conditions in vivo. Our findings support the inter-
pretation that promoting cell growth-proliferation and induc-
ing apoptosis are distinct properties of Myc proteins residing in
their amino terminal regions.
Conserved Myc functions from fly to humans. Myc plays an
essential role in controlling body size both in Drosophila and in
mice. In Drosophila, dMyc is thought to promote cell growth
(23, 34), while in mice, Myc appears to regulate both cell
proliferation (56) and growth (3, 13, 22, 33). Previous obser-
vations showed that proliferation defects of c-Myc-deficient
embryonic fibroblasts can be partially alleviated by dMyc ex-
pression (56). The whole-organism rescue of lethal dmyc mu-
tations by c-Myc expression presented here demonstrates that
human and Drosophila Myc proteins retain sufficiently similar
cellular functions to sustain a normal, integrated development.
Accordingly, we have shown that they regulate common target
genes involved in cell growth and apoptosis (dmyc, pitchoune,
modulo, and reaper). This ability of c-Myc to successfully re-
place dMyc in transcription is particularly striking in light of
the poor conservation of their N-terminal regions, including
the transactivation domain. For example, full identity is ob-
served in the region containing MbI motifs from mammalian,
bird, frog, and fish c-Myc proteins (18), whereas fly dMyc MbI
is highly divergent (19). The success of highly diverged mam-
malian c-Myc in regulating developmental processes in the fly
suggests that their regulatory networks are remarkably con-
served.
Isoform-specific c-Myc functions. The preceding results con-
firm that flies constitute a relevant physiological model for the
detailed comparison of the cellular and molecular properties
distinguishing c-Myc isoforms. To this end, we used the lethal
dmycPG45 allele that expresses the transcription activator Gal4
in place of dMyc. When expressed under dmycPG45 control,
dMyc and c-Myc1 were unable to rescue mutants, apparently
due to a dominant toxicity, even at low levels of expression
(18°C). c-Myc2 can restore viability but might also be toxic
when expressed at higher levels (26°C). In marked contrast,
c-MycS efficiently rescued males, even at elevated expression
levels (two transgene copies at 26°C) (Table 2). We can ex-
clude that this contrasting behavior reflects differential isoform
accumulation due to different protein stabilities or expression
levels because (i) the functionally distinct c-Myc1 and c-Myc2
isoforms accumulated similarly as detected by Western blotting
of Myc activity (F to J, arrows) are presumably due to the ap-Gal4 insertion. (Right) Effects of Myc overexpression on reaper (rpr) expression
(K to O). UAS-Myc transgenes were expressed in the posterior compartment of wing imaginal disks under en-Gal4 control, and rpr gene expression
was visualized by in situ hybridization. The approximate anteroposterior compartment boundary is indicated by the line in all panels (K to O). Clear
induction of rpr expression in the wing pouch was observed for dMyc and c-Myc1 (L and M), while weaker induction was detected for c-Myc2 (N).
c-MycS did not induce detectable rpr expression (compare panels K and O). The wing imaginal disks depicted are representative and were
photographed at the same magnification.
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(Fig. 2D) and (ii) for a given isoform, multiple independent
lines tested gave similar results in all functional tests (Table 2),
even when their expression levels varied (cf. c-Myc2 and
c-MycS) (Fig. 2D). We therefore infer that the functional dif-
ferences of c-Myc isoforms observed in the physiological con-
text of Drosophila development primarily reflect their distinct
molecular and cellular properties.
From several previous analyses of cultured cells, it was al-
ready suggested that the three c-Myc isoforms behave differ-
ently in controlling cell growth, proliferation, and apoptosis
(10, 31, 54, 55, 57). Here, we reexamined isoform-specific cel-
lular roles in the physiological context of the whole organism
where c-Myc can replace endogenous dMyc. Under these con-
ditions, we have found that c-Myc forms can be distinguished
by both quantitative and qualitative traits. All three modulate
cell size and cell cycle progression when overexpressed; how-
ever, they showed unequal efficiencies, since higher doses of
c-MycS were required for an equivalent effect on cell size
(Fig. 5). In agreement with this observation, c-MycS expressed
in dmyc mutant cells restored growth less fully than c-Myc2
(Fig. 3). Concerning their capacities to induce apoptosis, how-
ever, c-Myc isoforms show clear differences. Cells expressing
c-Myc1 showed high levels of apoptosis comparable to dMyc.
By contrast, the effect of c-Myc2 was much milder and c-MycS
had no discernible effect, even at levels sufficient to increase
cell size (two transgene copies) (Fig. 6 and data not shown).
Taken together, our data argue that of the three human
c-Myc isoforms, c-Myc1 is functionally comparable to dMyc.
Relative to c-Myc1, the c-Myc2 isoform is similarly competent
in inducing cell growth but attenuated for apoptosis, while
c-MycS lacking another 100 aa of its N-terminal region con-
serves an ability to stimulate cell growth but has lost proapop-
totic function. However, c-MycS is able to fully rescue dmyc
mutants, suggesting that proapoptotic activity is not required
for normal development. Conversely, the strong induction of
apoptosis by c-Myc1 compared to c-Myc2 (Fig. 6) might ex-
plain their differential toxicity in the developing fly.
The growth-versus-death choice is influenced by the c-Myc
N terminus. At the level of the primary amino acid sequence,
the only difference between the predominant vertebrate form
c-Myc2 and alternative c-Myc1 and c-MycS forms resides in
their NH2 terminal portion (Fig. 2A). In dmyc mutant Dro-
sophila, the cellular functions of c-Myc2 are sufficient to sustain
normal development. Remarkably, the alternatively initiated
c-Myc1, which harbors an additional 15 aa, enhanced all these
cellular functions and (in particular) apoptosis but led to dom-
inant lethality. This optional, leucine-initiated sequence is rel-
atively weakly conserved between the closely related human
and mouse proteins (6 identical amino acids out of 15). The
Drosophila dmyc locus also possesses an in-frame leucine
codon 15 aa upstream of the presumptive ATG initiation site.
If translated as in vertebrates, the resulting 15-aa sequence
would not be conserved (1 of 15 identical amino acids in
the three species). The poor overall conservation of this se-
quence argues against its specific interaction with molecular
partners and suggests an indirect role favoring a productive
conformation of c-Myc protein.
The N-terminal region common to c-Myc1 and c-Myc2 con-
tains a trans-activation domain that has been described as impor-
tant for numerous properties of the Myc molecule and/or for its
interactions with molecular partners in cultured cells (12, 21). In
the trans-activation domain, MbI is believed to play a role in
modulating c-Myc activity, while the integrity of MbII is essential
to normal c-Myc functions including cell cycle progression, apo-
ptosis, and transformation (41). c-MycS lacks the first 100 aa,
including the MbI motif, which harbors two phosphorylation sites
(Thr 58 and Ser 62) involved in the stability of c-Myc protein
through proteosomal degradation (15, 59). Mutations of these
sites are often linked to B-cell lymphomas (24, 29) and are cor-
related with reduced apoptotic potential (8, 11). Curiously, nei-
ther of these sites is conserved in dMyc (19). The truncated
c-MycS isoform rescues the growth defect of c-Myc null fibro-
blasts (57), but its ability to transactivate and induce apoptosis
remains a subject of debate (31, 57). The rescue obtained on
expressing c-MycS in developing Drosophila clearly shows that
this isoform possesses all necessary properties to sustain growth
and development, even though it is fully deficient in inducing
apoptosis. These results thus support the possibility of a direct
role for the first 100 aa of the N-terminal region, absent from
c-MycS, in the cellular choice between growth or death. This
choice will presumably reflect discriminating physical interactions
of a given N-terminal sequence with specific cofactors. The un-
coupling between growth and death functions obtained in c-MycS
but not in c-Myc2 transgenic flies thus offers an exciting new
opportunity to dissect the c-Myc genetic network(s) underlying
these two cellular processes.
Altogether, our results obtained in a physiological context
show that the three c-Myc isoforms are functionally different,
with the principal characteristic distinguishing them being their
abilities to induce apoptosis. In their normal context in mam-
malian cells, these c-Myc isoforms do not accumulate singly
but in specific combinations or ratios characteristic of a given
cellular status. Their different abilities to induce apoptosis may
thus explain why perturbing their balance can be associated
with cellular pathologies, including oncogenesis.
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